As many of you may have already read my personal experience with using Ivermectin, perhaps the data put forth in a recently published paper will not be surprising.
The paper was published by the Journal of Infection on Feb. 29.
The study covered an open-label trial that involved 2,157 ivermectin recipients and 3,256 who received typical care from June 23, 2021, to July 1, 2022. Participants were randomized and reported symptoms and recovery.
A recent headline from Epoch Health:
“People Who Received Ivermectin Were Better Off, Study Finds”
Continuing from that same Epoch Health piece:
“People who tested positive for COVID-19 and took ivermectin as a treatment recovered faster than a comparison group, a new study found. The time to self-reported recovery was a median of two days faster among the ivermectin recipients, according to the large UK study. The quicker recovery period was statistically significant.
People who received ivermectin were also less likely to be hospitalized or die, with 1.6 percent of ivermectin recipients being hospitalized or dying versus 4 percent of the comparison group, which received typical care, which in the UK is largely focused on managing symptoms. Ivermectin recipients also enjoyed a reduction of severe symptoms and sustained recovery, according to the study.”
Of course, as expected, some recalcitrants downplayed the results of this study. However, from my personal experience after last Thanksgiving with taking Ivermectin for Covid, the recalcitrants be damned!
3/14/24